🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Biomarkers in Prediction of AMI

RecruitingNAAges 18 Years - anyAllUniversity of Tartu
NCT06212921 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older * Initial decision in favour of further diagnostics of mesenteric ischaemia Exclusion Criteria: * Age \<18 years * Consent declined by patient or next of kin (delayed consent) * Chronic mesenteric ischaemia without an acute event * Immediate decision for withdrawal of further diagnostics and active treatment * Referral from another hospital with already established diagnosis of AMI * AMI diagnosed at surgery without previously having been considered
💊

What it tests

  • Sequential blood samples
📍

Where

2 sites
Tartu University Hospital
Tartu, Estonia
Lucerne Cantonal Hospital
Lucerne, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy